West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
July 25, 2024 at 11:00 am
Share
West Pharmaceutical Services, Inc. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 702.1 million compared to USD 753.8 million a year ago. Net income was USD 111.3 million compared to USD 155.1 million a year ago. Basic earnings per share from continuing operations was USD 1.52 compared to USD 2.08 a year ago. Diluted earnings per share from continuing operations was USD 1.51 compared to USD 2.06 a year ago.
For the six months, sales was USD 1,397.5 million compared to USD 1,470.4 million a year ago. Net income was USD 226.6 million compared to USD 295.1 million a year ago. Basic earnings per share from continuing operations was USD 3.09 compared to USD 3.96 a year ago. Diluted earnings per share from continuing operations was USD 3.06 compared to USD 3.91 a year ago.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows:
- own manufactured products (81.8%);
- products manufactured under contract (18.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
WEST PHARMACEUTICAL SERVICES, INC. 
